PCR | GenomeWeb

PCR

The company continues to build evidence for the added sensitivity offered by its urine- and blood-based liquid biopsy approach in an effort to engage clinicians.

The firm's reagents and disposables business was the biggest gainer, with a 12 percent revenue increase in the quarter. 

The firm saw decreases in its core diagnostics business that were offset in part by revenues from newly-acquired Magellan Diagnostics.

The test, which will be based on AmoyDx's proprietary real-time PCR technology, will identify cancer-associated mutations in the RAS gene family.

Sales of the firm's infectious disease and women's health products were credited with driving the year-over-year increase in revenues.

Devices and systems for isolating biomolecules and associated methods thereof
Digital analyte analysis
Methods and compositions for nucleic acid amplification
Method of detecting nucleic acid targets using a statistical classifier
Thermal Array
Method and kit for detection of microorganism